Television host and producer Andy Cohen has candidly revealed his use of GLP-1 weight loss medication, marking another high-profile celebrity discussion about these increasingly popular drugs. The 57-year-old Bravo executive shared his weight loss journey during Monday’s episode of his SiriusXM show Andy Cohen Live.
Cohen disclosed that he successfully lost a significant amount of weight over the summer by microdosing a GLP-1 medication. “I did, this summer, lose a good chunk of weight by micro-dosing a GLP-1,” the host revealed to his co-host John Hill during the September 9 broadcast.
STAR MAX)
The Watch What Happens Live host explained his decision to speak openly about his weight loss approach, emphasizing the importance of transparency given his public platform. “For 20 years, I have been asking people about their body regimens, and that I’ve been pretty vocal about every time I go on a diet here, etc., I do think it would be completely hypocritical not to share that I did this summer lose a good chunk of weight by microdosing a GLP-1 all summer,” Cohen stated during the radio show.
According to reports, Cohen’s weight loss journey resulted in approximately 25 pounds lost during the summer months. The television personality had previously discussed his weight concerns with his physician, who had recommended GLP-1 drugs on multiple occasions before Cohen decided to try the treatment.
Cohen’s revelation comes amid growing public interest in GLP-1 medications, which include brands like Ozempic and Wegovy. These drugs work by regulating appetite and blood sugar levels, leading to significant weight loss in many patients. The concept of “microdosing” these medications involves taking smaller doses than typically prescribed, potentially minimizing side effects while maintaining therapeutic benefits.
The entertainment industry has seen numerous celebrities discuss their experiences with weight loss medications, though Cohen’s approach of microdosing represents a variation that has gained attention in wellness circles. Medical experts note that GLP-1 receptor agonists have demonstrated effectiveness in clinical trials for both diabetes management and weight loss.
Cohen, known for his direct interviewing style on Watch What Happens Live, has built his career on asking probing questions about personal topics. His decision to share his own weight loss experience aligns with his philosophy of maintaining authenticity with his audience.
The Real Housewives executive producer’s disclosure adds to ongoing conversations about celebrity weight loss and the role of pharmaceutical interventions. Cohen has previously faced both praise and criticism for his comments about cast members’ weight loss journeys on various Bravo shows.
